معرفی
Chelsey R. Carter is an Assistant Professor of Public Health in the Department of Social and Behavioral Sciences at Yale School of Public Health with a secondary appointment in the Department of Anthropology. A Black feminist anthropologist of medicine, public health, and race from St. Louis, Missouri, Dr. Carter's interdisciplinary work bridges public health, anthropology, and critical race studies to address health inequities, particularly focusing on neurodegenerative diseases like ALS in Black communities.
Dr. Carter received her BA in Anthropology from Emory University (2012), followed by an MPH and PhD from Washington University in St. Louis (2021), and completed a Presidential Postdoctoral Fellowship at Princeton University (2022). Her educational background reflects her commitment to both anthropological theory and public health practice.
Her research examines the relationship between social determinants of health (particularly anti-Black racism, socioeconomic status, and gender) and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and motor neuron diseases. Dr. Carter employs ethnographic research and qualitative methodologies to investigate how embodied inequality impacts diagnosis, treatment, and engagement in clinical trials for Black individuals with ALS. She also leads research on precision medicine and genomic research in Black communities through The Black Genome Project and studies caregiving among persons impacted by ALS. Her scholarship has been funded by the National Science Foundation, the Andrew Mellon Foundation, and the Wenner Gren Foundation.
Analysis of Dr. Carter's recent publication trends reveals a strong focus on health equity, particularly examining how systemic racism manifests in medical settings and contributes to health disparities. Her work spans multiple domains including neurodegenerative diseases, HIV/AIDS care, genomics, and mental health, with consistent attention to intersectional approaches that consider race, gender, and socioeconomic status. A notable pattern in her scholarship is the use of qualitative and mixed methods to center the lived experiences of marginalized communities, challenging dominant biomedical paradigms through a Black feminist lens.
- Principal's Development Fund Visiting Scholar (2024)
- Distinguished Teaching Award from Yale School of Public Health (2023)
- Funding from the National Science Foundation
- Support from the Andrew Mellon Foundation
- Wenner Gren Foundation grant
Dr. Carter actively mentors students and has developed innovative teaching approaches, including her course 'Biomedical Justice: Public Health Critiques and Praxis,' which encourages students to bring their full selves into the classroom. Her research has been supported by significant grants that enable community-engaged work addressing health disparities. She emphasizes the importance of community partnerships in her research, ensuring that academic work serves and is accountable to the communities being studied.
Dr. Carter is Founder and Director of The LEITH (Lived Experiences Igniting Transformations in Health) Lab, which addresses Black invisibility and misdiagnosis for rare neurodegenerative and genetic diseases. The lab brings together persons and caregivers impacted by rare diseases, researchers, clinical providers, educators, students, and activists to develop more humanizing and critical approaches in the rare neurodegenerative field. The LEITH Lab's vision centers on advancing anti-racist research, fostering awareness through education, creating palliative networks for support, and developing a pipeline of health equity scholars.
